LearnGlossaryMarketStocksSuperinvestorsSign in

BLLN

BillionToOne, Inc.

Healthcare · $5.6B market cap

Verdict

We can't put a fair value on BLLN right now. Its earnings are too small compared with its share price for an earnings-based value to mean anything.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth106.2% a year✓
Free cash flow growth—?
Return on invested capital-17.7%✗

Follow BLLN

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds BLLN. In Q2 2026, 1 opened a position. Who we track

Polen Capital Management

Polen Capital Management · as of Q2 2026

$2.0M

16,975 shares

Moves in Q2 2026

New position: Polen Capital Management

About BillionToOne, Inc.

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY…

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works